ESOI Webinars
Online Education

Since 2015 ESOI has been proudly offering educational webinars on various topics related to oncologic imaging. The live webinars are very successful, well visited and attract many international participants from all over the world.

In 2018, ESOI will offer 15 online lectures, comprising 3 webinars especially dedicated to young radiologists and, for the first time, 2 multidisciplinary webinars. Each webinar will last approximately 60 minutes (50 min. presentation and 10 min. for discussion/questions).

Registration to the first 2 online educational webinars will be offered to every interested participant free of charge. Participation in webinars 3-15 will be free of charge but only open to active ESOI members. Membership is offered to full and associate members for 30,00 € and to residents for 10,00 €.

Webinar Certificate

We are pleased to announce that ESOI will offer a “Webinar Certificate”, starting in 2018. Everyone having attended at least 7 webinars in the current calendar year and correctly answered 70% of the related self-assessment questions will be issued this certificate at the end of the calendar year. The certificate will be personalised, individually stating each of the attended webinars, including short webinar descriptions. 

How to obtain the certificate

Please note that the self-assessment questions corresponding with the respective webinar will be shown on your computer directly after the webinar. As such you will only have this possibility to answer the questions. The questions will relate to the content of the respective webinar.
We do not recommend to follow the webinar in a group, as only the person registered and logged in to the respective webinar will be able to answer the self-assessment questions at the end and therefore recorded. 
We kindly ask for your understanding that currently ESOI Educational Webinars are not CME accredited.

M. D'Anastasi, Msida/MT
D. Regge, Turin/IT
G. Zamboni, Verona/IT

The ESOI Educational Webinars are kindly supported by Bracco.

Upcoming ESOI Webinars 2018
2. Cross-sectional imaging of renal tumours

R. Pozzi Mucelli, Verona/IT
February 26, 2018
18:00 CET

About the Presenter
Prof. Roberto Pozzi Mucelli graduated in Medicine from the University of Trieste with full marks and honours and conducted Visiting Research Programs at several universities in the United States. In 1994 he became a full professor of Radiology at the University of Trieste where he was also chairman of the Radiology Department between 2000 and 2004. Between 2004 and 2017 he chaired the department of radiology at the university of Verona. Meanwhile he was an invited speaker at many international and national meetings, performed for 11 years as Editor in Chief of “La Radiologia Medica”, the official journal of the Italian Society of Medical Radiology, and authored more than 350 papers on Diagnostic Radiology and textbooks on Computed Tomography, Magnetic Resonance Imaging and Pancreatic Imaging.

Webinar Description
In the following presentation the features and the respective roles of CT and MRI in the detection, characterization and staging of renal tumors will be revisited.
Computed Tomography (CT) represents a fundamental imaging technique in the diagnosis of renal tumors. Although many lesions are incidentally detected during an US examination of the upper abdomen, CT is essential for confirmation and for staging. Furthermore, CT also gives its contribution to the incidental detection of small renal tumors since about 1/3 of cases are diagnosed during a CT examination of the upper abdomen. Multidetector CT (MDCT) has further expanded its efficacy since thin slices obtained with this technique results in both increased detection and improved characterization. MDCT enables images to be obtained in different phases of opacification of the kidneys and in different sections, i.e. axial, coronal. When a renal mass is suspected (i.e. previous US diagnosis), a non contrast enhanced CT scan is obtained to serve as a baseline or measurement of CT densities after contrast administration. Following contrast administration, images in the corticomedullary phase are useful to show the degree of vascularity of the tumor, while images in the nephrographic phase are the most sensitive to detect and delineate even small renal masses. On the basis of the vascularity, renal tumor can be differentiated into hypervascular tumor, usually clear cell renal cell carcinoma, and hypovascular tumor, most commonly papillary renal cell carcinoma. In spite of the technological improvements of CT, limitation still exists especially as far differential diagnosis is concerned. The differential diagnosis with benign renal tumors such as angiomyolipoma is based on the recognition of fat but about 5-10% of these tumors do not contain significant amount of fat (fat-poor angiomyolipoma); therefore, these cases cannot be diagnosed with CT. Similar difficulties exists for oncocytoma whose incidence seems to be increased with the increased detection of small renal masses.
Magnetic resonance imaging (MRI) has nowadays comparable results with MDCT for detection, diagnosis and staging of renal masses. A careful MR technique has to be used to obtain both identification and characterization of renal tumors. Fast spin echo sequences, gradient echo – in phase and out of phase – sequences, diffusion weighted sequences and dynamic sequences with bolus injection of paramagnetic contrast agents are recommended to improve the detection and characterization of renal tumors. Also with MRI a number of imaging characteristics to differentiate the most common renal cell carcinomas have been shown, typically the high signal intensity in the T2-weighted sequences and the hypervascularity in the arterial phase of the contrast enhanced examination of the clear cell renal cell carcinoma, opposed to the hypointensity in the T2-weighted images and the hypovascularity of the papillary renal cell carcinoma. The limitation and pitfalls of MRI in the differential diagnosis with the benign renal masses will also be considered in this presentation.

Learning Objectives

This webinar will be offered free of charge to anyone interested. Registration will be accepted on a first come first serve base. 
Please register via the following link:​

Click on the iPad / iPhone to view the full webinar programmes for 2018.

Please note that the rogrammes are subject to possible modifications. 

Past Webinars 2018

1. Rectal Cancer: a multidisciplinary approach to imaging
R. Beets-Tan, Amsterdam/NL; G. Beets, Amsterdam/NL; B. van Triest, Amsterdam/NL

Past Webinars 2017 
1. Imaging of CNS tumours
P. Parizel, Antwerp/BE
2. Imaging and differential diagnosis of orbital tumours
U. Mueller-Lisse, Munich/DE

3. Imaging of lymphomas
M. Mayerhöfer, Vienna/AT

4. Imaging spectrum of primary and secondary mesenteric neoplasms
S. Nougaret, Montpellier/FR

5. Imaging of the treated pelvis: Pearls and pitfalls
E. Sala, New York/US

6. MR imaging of malignant diseases of the uterus
Y. Lakhman, New York/US

7. Practical advice in preparing successful scientific manuscripts
M. Reiser, Munich/DE

8. Imaging of recurrent prostate cancer
H. Vargas, New York/US

9. Bone metastases, how should we approach them with imaging?
T. Bäuerle, Erlangen/DE

10. PET-MRI in oncologic imaging - where do we stand?
V. Goh, London/UK

11. When to call a lesion an HCC?
G. Brancatelli, Palermo/IT

12. Current evidence for minimally invasive treatments in HCC
J. Ricke, Munich/DE

13. Diagnostic test studies: how I do it
M. Maas, Amsterdam/NL

14. Paediatric abdominal tumours
C. Granata, Genoa/IT

Past Webinars 2016

1. Staging of Rectal Cancer with MRI
R. Beets-Tan, Amsterdam/NL

2. Contrast-enhanced ultrasound-technical considerations and applications in oncologic imaging
D. Clevert, Munich/DE

3. Imaging dissemination pathways in head and neck cancer
M. Mack, Munich/DE

4. Whole body MRI in onology
V. Vandecaveye, Leuven/BE
5. Imaging of lung cancer: implications on management 
L. Bonomo, Rome/IT

6. Imaging of biliary tract tumours
R. Manfredi, Verona/IT

7. Staging of ovarian cancer - providing a GPS to patient management
H. Hricak, New York/US

8. Role of MRI in the diagnosis and management of prostate cancer
H. Vargas, New York/US
9. Tailoring breast imaging surveillance to the woman´s risk
F. Gilbert, Cambridge/UK

10. Imaging of bone tumours
G. Guglielmi, Foggia/IT

11. RECIST, CHOI and beyond
M. D'Anastasi, Munich/DE

Past Webinars 2015

1. DW in Oncologic Imaging
D. M.J. Lambregts, Maastricht/NL
2. CT Colonography
A. Laghi, Latina/IT
3. Cystic and solid pancreatic tumors
G. Zamboni, Verona/IT
4. Imaging the prostate - current status and future developments
J. Futterer, Nijmengen/NL
5. Update on Breast MRI
F. Sardanelli, Milan/IT
6. Structured Oncologic Reporting
W. Sommer, Munich/DE